| Unique ID issued by UMIN | UMIN000058092 |
|---|---|
| Receipt number | R000066391 |
| Scientific Title | Hepatolithiasis after pancreaticoduodenectomy |
| Date of disclosure of the study information | 2025/06/06 |
| Last modified on | 2026/07/03 15:10:11 |
Hepatolithiasis after pancreaticoduodenectomy
Hepatolithiasis after pancreaticoduodenectomy
Hepatolithiasis after pancreaticoduodenectomy
Hepatolithiasis after pancreaticoduodenectomy
| Japan |
Hepatolithiasis that occurred after pancreaticoduodenectomy
| Hepato-biliary-pancreatic surgery |
Malignancy
YES
The aim of this study is to investigate the risk factors and appropriate treatment for the hepatolithiasis after pancreaticoduodenectomy.
Safety,Efficacy
1. To evaluate the risk factors for hepatolithiasis after pancreaticoduodenectomy
2. To evaluate the appropriate treatment for hepatolithiasis after pancreaticoduodenectomy
Observational
| Not applicable |
| Not applicable |
Male and Female
Patients who underwent pancreaticoduodenectomy at our institution
None
314
| 1st name | Masahide |
| Middle name | |
| Last name | Hiyoshi |
Miyazaki Medical Association Hospital
Department of Surgery
880-2102
1173 Arita, Miyazaki-city, Miyazaki, Japan
+81-985-77-9101
mhiyoshi@med.miyazaki-u.ac.jp
| 1st name | Masahide |
| Middle name | |
| Last name | Hiyoshi |
Miyazaki Medical Association Hospital
Department of Surgery
880-2102
1173 Arita, Miyazaki-city, Miyazaki, Japan
+81-985-77-9101
mhiyoshi@med.miyazaki-u.ac.jp
Miyazaki Medical Association Hospital
None
Self funding
Research Ethics Committee, Faculty of Medicine, University of Miyazaki
5200 Kihara, Kiyotake Miyazaki
+81-985-85-9403
rinken@med.miyazaki-u.ac.jp
YES
#O-1502
Research Ethics Committee, Faculty of Medicine, University of Miyazaki
| 2025 | Year | 06 | Month | 06 | Day |
None
Published
International Journal of Surgery Open 64(2):p 90-94, April 2026. | DOI: 10.1097/IO9.0000000000000344
314
Among the 306 patients, 21 (6.9%) developed hepatolithiasis after PD. Univariate analysis revealed several risk factors for hepatolithiasis after PD, including heavy body weight (P = 0.0096), high body mass index (P = 0.0508), benign disease (P = 0.0109), preoperative drainage (P = 0.0680), and hepaticojejunostomy suture pitch greater than 2 mm (P = 0.0222). Multivariate analysis indicated that only a suture pitch greater than 2 mm (P = 0.0367) was a risk factor for hepatolithiasis after PD.
| 2026 | Year | 06 | Month | 23 | Day |
PD was performed in 314 patients. After excluding eight patients who underwent PD with hepatectomy, 306 patients were ultimately evaluated.
Of these, 17 were men and four were women, with a mean age of 67.9 +/- 10.3 years. The underlying disease was malignant in 15 patients and benign in 6.
Between January 2010 and December 2022, 314 patients underwent PD at our hospital.
A cross-sectional study was conducted to evaluate risk factors for hepatolithiasis after PD, including sex, age, height, body weight, body mass index (BMI), diabetes mellitus, final diagnosis, surgical time, blood loss, postoperative complications, preoperative biliary drainage, and postoperative biliary stent insertion.
None
We aimed to evaluate the risk factors and confirm the appropriate treatment for hepatolithiasis, particularly secondary hepatolithiasis, after pancreaticoduodenectomy.
Completed
| 2023 | Year | 12 | Month | 22 | Day |
| 2024 | Year | 01 | Month | 19 | Day |
| 2024 | Year | 01 | Month | 19 | Day |
| 2024 | Year | 12 | Month | 31 | Day |
None
| 2025 | Year | 06 | Month | 05 | Day |
| 2026 | Year | 07 | Month | 03 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000066391